No abstract available
Keywords:
COVID-19; DVT; Endovascular; PE; SARS CoV-2; Stroke; Thromboprophylaxis; VTE.
MeSH terms
-
Anticoagulants / adverse effects
-
Anticoagulants / therapeutic use*
-
COVID-19 / complications
-
COVID-19 / diagnosis
-
COVID-19 Drug Treatment*
-
Fibrinolytic Agents / adverse effects
-
Fibrinolytic Agents / therapeutic use*
-
Humans
-
Intermittent Pneumatic Compression Devices* / adverse effects
-
Risk Assessment
-
Risk Factors
-
Stroke / diagnosis
-
Stroke / epidemiology
-
Stroke / prevention & control*
-
Thromboembolism / diagnosis
-
Thromboembolism / etiology
-
Thromboembolism / prevention & control*
-
Thrombosis / diagnosis
-
Thrombosis / etiology
-
Thrombosis / prevention & control*
-
Treatment Outcome
Substances
-
Anticoagulants
-
Fibrinolytic Agents